2-(Cyclopropanecarboxamido)-N-(4-(cyclopropylmethoxy)-pyridin-3-yl)isonicotinamide

ID: ALA5271618

Chembl Id: CHEMBL5271618

Max Phase: Preclinical

Molecular Formula: C19H20N4O3

Molecular Weight: 352.39

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1cnccc1OCC1CC1)c1ccnc(NC(=O)C2CC2)c1

Standard InChI:  InChI=1S/C19H20N4O3/c24-18(13-3-4-13)23-17-9-14(5-8-21-17)19(25)22-15-10-20-7-6-16(15)26-11-12-1-2-12/h5-10,12-13H,1-4,11H2,(H,22,25)(H,21,23,24)

Standard InChI Key:  FYBXDJNRVFIQTH-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5271618

    ---

Associated Targets(Human)

ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3A Tclin Glycogen synthase kinase-3 alpha (3764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 352.39Molecular Weight (Monoisotopic): 352.1535AlogP: 2.87#Rotatable Bonds: 7
Polar Surface Area: 93.21Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.95CX Basic pKa: 5.84CX LogP: 1.86CX LogD: 1.85
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: -1.69

References

1. Luo G, Chen L, Burton CR, Xiao H, Sivaprakasam P, Krause CM, Cao Y, Liu N, Lippy J, Clarke WJ, Snow K, Raybon J, Arora V, Pokross M, Kish K, Lewis HA, Langley DR, Macor JE, Dubowchik GM..  (2016)  Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors.,  59  (3): [PMID:26751161] [10.1021/acs.jmedchem.5b01550]

Source